TOI 0.36 The Oncology Institute, Inc.
| Range: | 0.273-2.655 | Vol Avg: | 123550 | Last Div: | 0 | Changes: | 0.03 |
| Beta: | 0.61 | Cap: | 0.03B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jun 04 2020 | Empoloyees: | 800 | ||
| CUSIP: | 68236X100 | CIK: | 0001799191 | ISIN: | US68236X1000 | Country: | US |
| CEO: | Dr. Daniel Virnich FACHE, M.B.A., M.D. | Website: | https://theoncologyinstitute.com | ||||
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow